Details of the Drug | DrugMAP

General Information of Drug (ID: DMAPGUI)

Drug Name

CC-11006

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C18H17N3O5
Canonical SMILES: C1CC1C(=O)NCC2=C3C(=CC=C2)C(=O)N(C3=O)C4CCC(=O)NC4=O
InChI: 1S/C18H17N3O5/c22-13-7-6-12(16(24)20-13)21-17(25)11-3-1-2-10(14(11)18(21)26)8-19-15(23)9-4-5-9/h1-3,9,12H,4-8H2,(H,19,23)(H,20,22,24)
InChIKey: ZBXHNCURDISBRO-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 10155135
CAS Number: 444287-44-9
TTD ID: D0J0JT

References

1	ClinicalTrials.gov (NCT00458159) A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes. U.S. National Institutes of Health.